DNA binding proteins that associates with chromatin and has the ability to bend DNA. Binds preferentially single-stranded DNA. Involved in V(D)J recombination by acting as a cofactor of the RAG complex. Acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS). Belongs to the HMGB family. Note: This description may include information from UniProtKB.
Protein type: DNA-binding; Nuclear receptor co-regulator
Cellular Component: nucleoplasm; extracellular space; protein complex; cell; perinuclear region of cytoplasm; nuclear chromatin; cytoplasm; condensed chromosome; nucleus
Molecular Function: protein domain specific binding; drug binding; transcription factor binding; protein binding; RAGE receptor binding; four-way junction DNA binding; DNA binding; double-stranded DNA binding; damaged DNA binding; chromatin binding; DNA bending activity; transcription factor activity; single-stranded DNA binding; chemoattractant activity
Biological Process: positive regulation of nuclease activity; establishment and/or maintenance of chromatin architecture; DNA topological change; apoptosis; positive regulation of transcription, DNA-dependent; programmed cell death; response to lipopolysaccharide; defense response to Gram-negative bacterium; DNA geometric change; regulation of neurogenesis; positive chemotaxis; DNA ligation during DNA repair; positive regulation of megakaryocyte differentiation; DNA fragmentation during apoptosis; positive regulation of DNA binding; cell structure disassembly during apoptosis; response to drug; V(D)J recombination; positive regulation of erythrocyte differentiation; male gonad development; spermatid nuclear differentiation; chromatin remodeling; regulation of transcription from RNA polymerase II promoter; nucleosome assembly; defense response to Gram-positive bacterium; inflammatory response to antigenic stimulus; response to steroid hormone stimulus; positive regulation of endothelial cell proliferation; positive regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.